(Q38812924)

6 September 2017

The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study (English)

1 reference

6 September 2017

6

Till Bärnighausen

0 references

Jennifer Manne-Goehler

4

object named as

Jennifer Manne-Goehler

1 reference

6 September 2017

5

Rifat Atun

1 reference

6 September 2017

Sebastian Vollmer

7

1 reference

ORCID Public Data File 2021

author name string

Christian Bommer

1

1 reference

PubMed ID

28456416

6 September 2017

Esther Heesemann

2

1 reference

PubMed ID

28456416

6 September 2017

Vera Sagalova

3

1 reference

6 September 2017

26 April 2017

1 reference

The Lancet: Diabetes & Endocrinology

6 September 2017

1 reference

6 September 2017

5

1 reference

6 September 2017

6

1 reference

6 September 2017

423-430

1 reference

Cost-of-illness studies in diabetes mellitus

6 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930097-9

7 January 2021

The Economic Costs of Type 2 Diabetes: A Global Systematic Review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930097-9

7 January 2021

Economic costs of diabetes in the U.S. in 2012

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930097-9

7 January 2021

Comparing cost-of-illness estimates from alternative approaches: an application to diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930097-9

7 January 2021

Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930097-9

7 January 2021

Economic burden of diabetes mellitus in the WHO African region

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930097-9

7 January 2021

Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930097-9

7 January 2021

The cost burden of diabetes mellitus: the evidence from Germany--the CoDiM study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930097-9

7 January 2021

Medical care and payment for diabetes in China: enormous threat and great opportunity.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930097-9

7 January 2021

The economic costs of diabetes: a population-based study in Tehran, Iran.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930097-9

7 January 2021

Excess cost burden of diabetes in Southern India: a clinic-based, comparative cost-of-illness study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930097-9

7 January 2021

Direct costs in impaired glucose regulation: results from the population-based Heinz Nixdorf Recall study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930097-9

7 January 2021

The value of productivity: human-capital versus friction-cost method.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930097-9

7 January 2021

10.1016/S2213-8587(17)30097-9

Identifiers

DOI

1 reference

6 September 2017

1 reference

PubMed ID

28456416